Adverse events
palpitations, migraine, flushing
ADVERSE EVENTS, MIGRAINE
The proportion of patients reporting warm sensations, palpitations and flushing in the erenumab group was lower than in the placebo group (Adverse eventsReports of adverse events following administration of calcitonin gene-related peptide (CGRP) and cilostazol in individuals with migraine randomized to erenumab or placebo.Warm sensations and palpitations are common adverse events after intake of cilostazol in individuals with migraine.